Patent Terms Extended Under 35 U.S.C.   156
   Certificates extending the terms of the following patents were issued
on October 23, 1998.
   U.S. Patent No. Re. 34,617; Granted May 24, 1994, to Ronald J. Jandacek,
et al.; Owner of Record: The Procter and Gamble Company; Title:
Vitamized Compositions for Treating Hypocholesterolemia; Classification:
514/23; Product Trade Name: OLEAN   (olestra); Original Expiration
Date: February 12, 1996; Term Extended: two years; Extended Expiration
Date: January 30, 1998.
   U.S. Patent No. 4,947,840; Granted August 14, 1990, to Ioannis V. Yannas
et al.; Owner of Record: Massachusetts Institute of Technology; Title:
Biodegradable Templates for the Regeneration of Tissues; Classification:
128/156; Product Trade Name: INTEGRA    Artificial Skin; Original
Expiration Date: August 21, 2007; Term Extended: 923 days; Extended
Expiration Date: March 1, 2010.
   U.S. Patent No. 5,008,256; Granted April 16, 1991, to John W.
Clitherow; Owner of Record: Glaxo Group Limited; Title: Salts for
Ranitidine and Complexes of Bismuth with Carboxylic Acids, and
Pharmaceutical Compositions Thereof, Classification: 514/184; Product
Trade Name: TRITEC    (ranitidine bismuth citrate); Original Expiration
Date: July 17, 2009; Term Extended: 387 days; Extended Expiration Date:
August 8, 2010.
   U.S. Patent No. 5,019,583; Granted May 28, 1991, to Paul L. Feldman et
al.; Owner of Record: Glaxo Wellcome Inc.; Title:
N-Phenyl-N-(4-Piperidinyl)Amides Useful as Analgesics; Classification:
514/327; Product Trade Name: ULTIVA    Injection (remifentanil
hydrochloride); Original Expiration Date: February 15, 2009; Term
Extended: 512 days; Extended Expiration Date: July 12, 2010.
   U.S. Patent No. 5,142,051; Granted August 25, 1992, to Antonin Holy et
al.; Owner of Record: Institute of Organic Chemistry and Biochemistry of
the Academy of Sciences of the Czech Republic and Rega Institut; Title:
N-Phosphonylmethoxyalkyl Derivatives of Pyrimidine and Purine Bases and
a Therapeutical Composition Therefrom with Antiviral Activity;
Classification: 544/243; Product Trade Name: VISTIDE    (cidofovir);
Original Expiration Date: August 25, 2009; Term Extended: 305 days;
Extended Expiration Date: June 26, 2010.

              Patent Terms Extended Under 35 U.S.C.    156(d)(5)

   An order extending the term of the following patent was issued on
October 23, 1998.
   U.S. Patent No. 4,291,708; Granted September 29, 1981, to Ephraim H.
Frei, et al.; Owner of Record: Yeda Research & Development Co; Title:
Apparatus and Method for Detecting Tumors in Tissue: 128/734; Product
Trade Name: T-SCAN   ; Original Expiration Date: November 2, 1998; Term
Extended: one year; Extended Expiration Date: November 2, 1999.